CAS 874638-80-9

(2R)-2-Deoxy-2-fluoro-2-methyl-D-erythro-pentonic acid γ-lactone 3,5-dibenzoate

Description:

(2R)-2-Deoxy-2-fluoro-2-methyl-D-erythro-pentonic acid γ-lactone 3,5-dibenzoate is a synthetic compound characterized by its unique structural features, including a fluorine atom and a methyl group attached to the second carbon of a pentonic acid derivative. This compound exists as a lactone, indicating the presence of a cyclic ester formed from the reaction of a hydroxyl group and a carboxylic acid within the molecule. The presence of the dibenzoate moiety suggests that it has two benzoate groups esterified to the lactone, which can influence its solubility, stability, and biological activity. The stereochemistry at the second carbon (2R) is crucial for its interaction with biological systems, potentially affecting its pharmacological properties. This compound may be of interest in medicinal chemistry and drug design due to its structural complexity and potential applications in targeting specific biological pathways. Its CAS number, 874638-80-9, allows for precise identification and retrieval of information related to its properties and applications in scientific literature.

Formula: C₂₀H₁₇FO₆

InChI: InChI=1S/C20H17FO6/c1-20(21)16(27-18(23)14-10-6-3-7-11-14)15(26-19(20)24)12-25-17(22)13-8-4-2-5-9-13/h2-11,15-16H,12H2,1H3/t15-,16-,20-/m1/s1

InChI key: InChIKey=OUKYMZJNLWKCSO-JXXFODFXSA-N

SMILES: C(OC(=O)C1=CC=CC=C1)[C@@H]2[C@@H](OC(=O)C3=CC=CC=C3)[C@@](C)(F)C(=O)O2

Synonyms:

• (2R)-2-Deoxy-2-fluoro-2-methyl-<span class="text-smallcaps">D</span>-erythro-pentonic acid γ-lactone 3,5-dibenzoate
• (2R)-2-Deoxy-2-fluoro-2-methyl-D-erythropentonic acid gamma-lactone 3,5-dibenzoate
• (2R,3R,4R)-3-(benzoyoxy)-4-fluoro-4-methyl-5-oxotetrahydrofuran-2yl)methyl Benzoate
• 3,5-di-O-benzoyl-2-deoxy-2-fluoro-D-ribono-Y-lactone
• 3,5-dibenzoate-(2R)-2-deoxy-2-fluoro-2-methyl-D-erythro-Pentonic acid, γ-lactone
• <span class="text-smallcaps">D</span>-erythro-Pentonic acid, 2-deoxy-2-fluoro-2-methyl-, γ-lactone, 3,5-dibenzoate, (2R)-
• D-erythro-Pentonic acid, 2-deoxy-2-fluoro-2-methyl-, γ-lactone, 3,5-dibenzoate, (2R)-
• [(2R,3R,4R)-3-(benzoyloxy)-4-fluoro-4-methyl-5-oxotetra-2-yl)methyl benzoate
• (2R)-2-Deoxy-2-fluoro-2-methy-D- erythropentonic acid gamma-lactone 3,5- dibenzoate
• (2R)-2-Deoxy-2-fluoro-2-methyl-D-erythro-pentonic acid γ-lactone 3,5-dibenzoate
• ((2R,3R,4R)-3-benzoyloxy)-4-fluoro-4-methyl-5-oxotetrahydrofuran-2-yl)methyl benzoate
• ((2R,3R,4R)-3-(Benzoyloxy)-4-Fluoro-4-Methyl-5-Oxotetrahydrofuran-2-Yl) Methyl Benzoate
• PSI-6130 interMediate
• Sofosbuvir Intermediate 1
• 3,5-Di-O-benzoyl-2-deoxy-2-fluoro-2C-methyl-D-arabino-1,4-lactone
• (2R)-2-Deoxy-2-fluoro-2-Methyl-D-erythropentonic acid
• 3,5-Di-O-benzoyl-2-deoxy-2-fluoro-2C-methyl-D-ribono-1,4-lactone
• (S)-isopropyl 2-(((S)-(((2R,3R,4R,5S)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate
• ((2R,3R,4R)-3-(DENZOYLOXY)-4-FLUORO-4-METHYL-5-OXOTETRAHYDROFURAN-2-YL)METHYL BENZOATE
• SofosBuvir Impurity 46
• (2R-3R,4R)-3-(Benzoyzxy)-4-Fluoro-4-Methyl-5-Oxotetrahydrofuran-2Yl)Methyl Benzoate
• (2R,3R,4R)-2-[(benzoyloxy)methyl]-4-fluoro-4-methyl-5-oxooxolan-3-yl benzoate
• (2R)-2-Deoxy-2-fluoro-2-methyl-D-erythropentonic acid γ-lactone 3,5-dibenzoate
• Sofosbuvir Impurity 30
• 4-amino-1-[(2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]pyrimidin-2-one
• Sofosbuvir intermediate
• ((2R,3S,4R)-3-(benzoyloxy)-4-fluoro-4-methyl-5-oxotetrahydrofuran-2-yl)methyl benzoate
• InterMediate of Sofosbuvir
• ((2R,3R,4R)-3-(benzoyloxy)-4-fluoro-5-oxotetrahydrofuran-2-yl)methyl benzoate
• SFBM
• Sofosbuvir Impurity 101
• 3. ((2R,3R,4R)-3-(benzoyloxy)-4-fluoro-4-Methyl-5-oxotetra
• Sofosbuvir INT 3
• Di-O-benzoyl-2-deoxy-2-fluoro-2-C-Methyl-D
• Methyl ((2R,3R,4R)-3-(benzoyloxy)-4-fluoro-4-Methyl-5-oxotetrahydrofuran-2-yl) benzoate
• SF-X1
• nterMediate of Sofosbuvir
• 3,5-di-O-benzoyl-2-deoxy-2-fluoro-D-ribono-γ-latone
• 3,5-Di-O-benzoyl-2-deoxy-2-fluoro-2-C-Methyl-D-ribono-γ-lactone
• Sofosbuvir imp-2
• (2R)-2-DEOXY-2-FLUORO-2-METHYL-D-ERYTHRO
• ((2R,3R,4R)-3-(BENZOYLOXY)-4-FLUORO-4-METHYL-5-OXOTETRAHYDROFURAN-2-YL)METHYL BENZOATE 874638-80-9
• 3,5-di-O-benzoyl-2-deoxy-2-fluoro-2-C-methyl-D-ribono-γ-latone

(2R,3R,4R-3-Benzoyloxy-4-fluoro-4-methyl-5-oxotetrahydrofuran-2-yl)methyl benzoate

CAS: 874638-80-9

Formula: C₂₀H₁₇FO₆

Purity: 97%

Color and Shape: Solid

Molecular weight: 372.3438

Ref: IN-DA00361X

((2R,3R,4R)-3-(BENZOYLOXY)-4-FLUORO-4-METHYL-5-OXOTETRAHYDROFURAN-2-YL)METHYL BENZOATE

CAS: 874638-80-9

Purity: 95.0%

Color and Shape: Solid

Molecular weight: 372.3479919433594

Ref: 10-F390378

Sofosbuvir Impurity 30

CAS: 874638-80-9

Formula: C₂₀H₁₇FO₆

Molecular weight: 372.35

Ref: 4Z-S-055034

3,5-Di-O-benzoyl-2-deoxy-2-fluoro-2C-methyl-D-ribono-1,4-lactone

CAS: 874638-80-9

3,5-Di-O-benzoyl-2-deoxy-2-fluoro-2C-methyl-D-ribono-1,4-lactone is a synthetic compound with the molecular formula C6H12F6O8. It has a molecular weight of 536.14 and an empirical formula of C24H32F6O8. 3,5-Di-O-benzoyl -2,3,4,5,-tetra-, 2C-, methyl -D-, ribo-, 1,4-, lactone is soluble in water and it can be synthesized from D-(+)-glucose and methyl 4-(trifluoromethyl)benzoate in three steps. The structure of 3,5 Di O benzoic acid was first determined by XRD analysis. The compound is a white crystalline solid with melting point at 180°C to 181°C and boiling

Formula: C₂₀H₁₇FO₆

Purity: Min. 97 Area-%

Color and Shape: White Off-White Powder

Molecular weight: 372.34 g/mol

Ref: 3D-MD09387

Sofosbuvir Impurity 2

CAS: 874638-80-9

Formula: C₂₀H₁₇FO₆

Molecular weight: 372.4

Ref: ST-EA-CP-S45024